Press release
Seeds Market Dynamics and Global Forecast to 2026
The global seed market size is estimated to account for a value of USD 63.0 billion in 2021 and is projected to grow at a CAGR of 6.6% from 2021, to reach a value of USD 86.8 billion by 2026. The growing demand for seeds from the food, beverage, animal feed, and biofuels industry is driving the growth of the market. Demand for seeds has witnessed steady growth in countries such as China and India. With these countries accounting for the largest population, an ever-increasing demand for food grains also drives the seeds market growth. In developed markets, farmers are trying to maintain the crop yield and increase their returns. This sustained approach from developed and developing countries in agricultural practices has been driving the global seeds market growth.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=126130457
Driver: High adoption of biotech crops
Biotechnology is being used to develop stress-tolerant and more nutritious crop varieties to protect natural resources. According to the International Service for the Acquisition of Agri-biotech Applications (ISAAA), the area under bio tech crops has increased 113-fold from 1.7 million hectares in 1996 to 191.7 million hectares in 2018 – this makes biotech crops the fastest adopted crop technology in recent times. Biotech crops have expanded beyond the major crops such as corn, soybeans, cotton, and canola to other crops such as alfalfa, sugar beets, papaya, squash, eggplant, potatoes, and apples. Additionally, biotech crop research conducted by public sector institutions include rice, banana, potatoes, wheat, chickpea, pigeon pea, and mustard with various economically-important and nutritional quality traits beneficial to food producers and consumers in developing countries.
Constraint: High R&D expenses on quality seed development lead to high seed price
The seed industry is one of the most R&D intensive industries. The R&D spends vary between companies depending on the company’s strategy and choice of techniques. This is in stark contrast with the crop protection industry, where a majority of the leading companies have a similar percentage of the sale on R&D. Due to erratic climatic conditions and high demand for food from end consumers, the adoption of genetically-modified seeds is higher among farmers. The cost of developing GM seeds is higher, thereby pushing up the price of the seed. Certain companies have a pioneering position in the development of GM seeds with specific traits (insect resistance and herbicide tolerance), due to which they are in a better position to charge a premium for their products (seeds). Hybrid seeds and organic seeds of different varieties of vegetables and fruits such as tomatoes, apples, grapes, and melons also cost higher than the average price of seed; farmers could use existing seeds from the previous harvest cycle to reduce the overall expenditure on seeds. This could have a negative impact on the growth of the market for seeds.
Opportunity: Molecular breeding in seeds
The molecular breeding technique is the most promising technology that is used for developing seeds. Gene-tagged markers help in reducing the time consumed in the selection of the desired genes in progenies and parents. Marker-assisted selection, QTL analysis, and genetic transformation are some of the key techniques that have been used as tools for oilseed molecular breeding. Chinese breeders have identified various traits such as high-quality grain and yield, pest resistance, and abiotic tolerance with the help of QTL analysis. To get better and faster results, many genetic breeding techniques have been developed in the past few years.
Challenge: Commercialization of fake hybrid seeds and counterfeit of products
According to the International Seed Federation (ISF), there has been an increase in illegal seed practices, including counterfeit seeds, fake seeds, fraudulent labelling, infringement of intellectual property, and regulatory offenses. Over the years, there has been an increase in the number of incidents reported the counterfeit of labels and bags of seeds being sold in developing nations. The phenomenon is largely driven by the fact that low-income farmers are not in a position to purchase seeds in large quantities. This paves the way for the sellers to breakdown the bags, repack them in smaller volumes and sell them in loose form. This creates an opportunity for adulteration.
Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=126130457
Some of the major players operating in the seeds market include BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), KWS SAAT SE (Germany), Land O’ Lakes (US), Sakata Seed Corporation (Japan), Groupe Limagrain (France), Corteva Agriscience (US), United Phosphorous Limited (India), DLF (Denmark), Longping Hi-tech (China), Rallis India Limited (India), Enza Zaden (The Netherlands), Takii & Co. Ltd (Japan), and Barenbrug Holding B.V (Netherlands). They also have manufacturing facilities along with strong distribution networks across these regions.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Seeds Market Dynamics and Global Forecast to 2026 here
News-ID: 2527295 • Views: …
More Releases from Markets and Markets

Controlled-release Fertilizers Market Latest Trends, Demands, Overview and Analy …
The controlled-release fertilizers market is experiencing notable growth, estimated at USD 2.2 billion in 2023 and projected to reach USD 2.9 billion by 2028. This reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period. The demand for controlled-release fertilizers is increasing due to their benefits in enhancing nutrient efficiency, reducing environmental impact, and supporting sustainable agricultural practices.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=136099624
These fertilizers are prized for their ability…

Gelatin Market is Projected to Reach $5.6 billion by 2029, at a CAGR of 6.9% fro …
According to a research report titled "Gelatin Market by Source (Animal, Plants), By Applications (Food & Beverages, Pharmaceuticals, Health & Nutrition, Cosmetics, Personal Care, Animal Feed), Type (Type A, Type B), Function (Thickener, Stabilizer, Gelling Agent) - Global Forecast to 2029," published by MarketsandMarkets, the gelatin market is poised for significant growth. The market, valued at USD 4.0 billion in 2024, is projected to reach USD 5.6 billion by 2029,…

Facility Management Market Status, Revenue, Growth Rate, Services and Solutions
According to a research report "Facility Management Market by Offering (Solutions (IWMS, BIM, Facility Operations & Security Management) and Services), Vertical (BFSI, Retail, Construction & Real Estate, Healthcare & Life sciences) and Region - Global Forecast to 2028" published by MarketsandMarkets, the facility management market is estimated at USD 49.6 billion in 2023 to USD 94.8 billion by 2028, at a Compound Annual Growth Rate (CAGR) of 13.8%.
Download PDF Brochure:…

Endpoint Security Market Size, Revenue, Growth Rate Analysis and Forecast 2024
According to a research report "Endpoint Security Market by Solution (Endpoint Protection Platform and Endpoint Detection and Response), Service, Deployment Mode, Organization Size, Vertical (Healthcare, Retail and eCommerce, and Government), and Region - Global Forecast to 2024", published by MarketsandMarkets, the global endpoint security market size is expected to grow from USD 12.8 billion in 2019 to USD 18.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…